Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Remmers

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
European Urology Open Science|January 13, 2025
Impact of Additional Active Treatment for Prostate Cancer on Health-related Quality of Life of Men: Results from the EUPROMS 2.0 1-year Follow-up SurveyLionne D F Venderbos, Sebastiaan Remmers, André Deschamps, et al.
Annals of Diagnostic Pathology|October 30, 2021
Improving the prediction of biochemical recurrence after radical prostatectomy with the addition of detailed pathology of the positive surgical margin and cribriform growthSebastiaan Remmers, Eva Hollemans, Daan Nieboer, et al.
Journal of Personalized Medicine|March 26, 2025
A Personalized, Risk-Based Approach to Active Surveillance for Prostate Cancer with Takeaways from Broader Oncology Practices: A Mixed Methods ReviewJeroen J Lodder, Sebastiaan Remmers, Roderick C N van den Bergh, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2026
Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer RotterdamSanne F Westerhout, Sebastiaan Remmers, Chris H Bangma, et al.
European Urology Oncology|January 11, 2026
Living with a Prostate Cancer Patient: Real-world Evidence from the Europa Uomo Prostate Cancer Partners in Europe Research StudyLionne D F Venderbos, Sebastiaan Remmers, André Deschamps, et al.
European Urology Open Science|July 11, 2022
External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening CohortJan Chandra Engel, Thorgerdur Palsdottir, Donna Ankerst, et al.
European Urology Open Science|April 20, 2026
Who, When, and How: Watchful Waiting in the ERSPC RotterdamJeroen J Lodder, Esmée F H Mulder, Sebastiaan Remmers, et al.
BMC Urology|July 19, 2022
Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance studyPaola Dordoni, Sebastiaan Remmers, Riccardo Valdagni, et al.
Cancers|March 29, 2023
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012-2018: A Retrospective, Population-Based StudyBenjamin E White, Beth Russell, Sebastiaan Remmers, et al.
BJU International|May 10, 2024
Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate CancerNiko Pasanen, Kirsi Talala, Sebastiaan Remmers, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
European Urology Open Science|January 13, 2025
Impact of Additional Active Treatment for Prostate Cancer on Health-related Quality of Life of Men: Results from the EUPROMS 2.0 1-year Follow-up SurveyLionne D F Venderbos, Sebastiaan Remmers, André Deschamps, et al.
Annals of Diagnostic Pathology|October 30, 2021
Improving the prediction of biochemical recurrence after radical prostatectomy with the addition of detailed pathology of the positive surgical margin and cribriform growthSebastiaan Remmers, Eva Hollemans, Daan Nieboer, et al.
Journal of Personalized Medicine|March 26, 2025
A Personalized, Risk-Based Approach to Active Surveillance for Prostate Cancer with Takeaways from Broader Oncology Practices: A Mixed Methods ReviewJeroen J Lodder, Sebastiaan Remmers, Roderick C N van den Bergh, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2026
Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer RotterdamSanne F Westerhout, Sebastiaan Remmers, Chris H Bangma, et al.
European Urology Oncology|January 11, 2026
Living with a Prostate Cancer Patient: Real-world Evidence from the Europa Uomo Prostate Cancer Partners in Europe Research StudyLionne D F Venderbos, Sebastiaan Remmers, André Deschamps, et al.
European Urology Open Science|July 11, 2022
External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening CohortJan Chandra Engel, Thorgerdur Palsdottir, Donna Ankerst, et al.
European Urology Open Science|April 20, 2026
Who, When, and How: Watchful Waiting in the ERSPC RotterdamJeroen J Lodder, Esmée F H Mulder, Sebastiaan Remmers, et al.
BMC Urology|July 19, 2022
Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance studyPaola Dordoni, Sebastiaan Remmers, Riccardo Valdagni, et al.
Cancers|March 29, 2023
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012-2018: A Retrospective, Population-Based StudyBenjamin E White, Beth Russell, Sebastiaan Remmers, et al.
BJU International|May 10, 2024
Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate CancerNiko Pasanen, Kirsi Talala, Sebastiaan Remmers, et al.
Pageof 10